Vol. 19 No. 2 (2013)

DOI: https://doi.org/10.5912/jcb.v19i2

Published: 2013-04-01

Commentary

Capturing Value

G. Steven Burrill
- Requires Subscription PDF (USD 25)
Defining valuable information in a shifting industry

Andrew F Bourgoin
- Requires Subscription PDF (USD 25)
Commercial Biotechnology in Mexico

Minerva Valdes, Fernando Quezada
- Requires Subscription PDF (USD 25)

Article

Technology Transfer: Bridging academic research and society â€“ a communicative approach

Martin Vad Bennetzen, Lars Stig MÃ¸ller
- Requires Subscription PDF (USD 25)
The financial ecosystem available to early-stage biotechnology firms and its misalignment with interests of these firms, of the biotechnology industry and with global disease burden

Gergely Toth
- Requires Subscription PDF (USD 25)
A Patient Centric Commercial Model for Cancer Care

Sanjay Rao
- Requires Subscription PDF (USD 25)
Developing Cell Therapies: Enabling cost prediction by value systems modeling to manage developmental risk.

Mark Joseph McCall, David John Williams
- Requires Subscription PDF (USD 25)
Challenges and prospects for monoclonal antibodies in China

Honghao Shi, Meiwan Chen, Yunzhen Shi, Hao Hu, Yitao Wang
- Requires Subscription PDF (USD 25)

From the Boardroom

A Business Perspective on IP: Open Innovation vs. Open Source in Commercializing Biotechnology

Arthur A. Boni
- PDF
Getting Social with Biotechnology Business Development

Tim McCready
- Requires Subscription PDF (USD 25)

Legal and Regulatory Updates